Nessan Bermingham

Nessan Bermingham

Founder at
Liberate Bio, Inc.

Net worth: 438 574 $ as of 30/08/2026

53 year
Health Technology
Consumer Services
Finance

Profile

Dr. Nessan Bermingham is an Operating Partner at Khosla Ventures LLC, a Chairman at F-star Therapeutics Ltd., a Chairman at Korro Bio, Inc., a Chairman at F-star Biotechnology Ltd., an Executive Chairman at Korro Bio, Inc. (United States), a Member at Baylor College of Medicine and a President, Treasurer, Secretary & Director at Liberate Bio, Inc. He is on the Board of Directors at Deep Genomics, Inc., Charm Therapeutics Ltd. and Liberate Bio, Inc. Dr. Bermingham was previously employed as a Chief Executive Officer by EveryONE Medicines, Inc., a Chairman by F-star Therapeutics, Inc., an Executive Chairman by Triplet Therapeutics, Inc., an Executive Chairman by Xilio Therapeutics, Inc., an Executive Chairman by F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH, a Venture Partner by Atlas Venture Advisors, Inc., a President, Chief Executive Officer & Director by Intellia Therapeutics, Inc., a Senior Advisor by Alnylam Pharmaceuticals, Inc., a Chief Executive Officer by Tal Medical, Inc., a Founder & Managing Partner by Bio Equity Capital LLC, a Partner by Omega Funds, an Analyst by UBS Warburg, Inc., a Non-Executive Director by Arrow Therapeutics Ltd., a Consultant by LAB International, Inc., a Board Member by Renovo Services LLC, and a Co-Founder by Serentis Ltd. He also served on the board at F-Star Therapeutics, Inc. (United States), F-star Alpha Ltd., F-Star Beta Ltd., F-Star Delta Ltd., Alliance for Regenerative Medicine, Cellzome Ltd., Navitor Pharmaceuticals, Inc., NsGene A/S and PreciSense A/S.
He received his undergraduate degree from Queen's University Belfast A.F.C.
and a doctorate degree from Imperial College London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.24%
09/06/2026 35,114 ( 0.24% ) 438 574 $ 30/08/2026

Nessan Bermingham active positions

CompaniesPositionStart
Corporate Officer/Principal -
Chairman -
Private Equity Investor 30/11/2021
Director/Board Member -
Director/Board Member 05/01/2023
Founder -
Founder -
Chairman 09/09/2018

Former positions of Nessan Bermingham

CompaniesPositionEnd
Chief Executive Officer 09/07/2024
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Nessan Bermingham's experience

Training of Nessan Bermingham

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

54

1st degree connections

35

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies35

Health Technology

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

Consumer Services

Electronic Technology

Finance

Health Technology

Commercial Services

UBS Warburg, Inc.

Finance

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Nessan Bermingham
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!